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Abstract  
Chronic anal fissure is one of the most frequent anorectal disorders. Symptoms vary but typically 
include bright red rectal bleeding, itching and discomfort or pain during and after defecation. 
Treatment has undergone a transformation in recent years from surgical to medical, all approaches 
sharing the goal of reducing the spasm. 
According to the researched treatment guidelines and the experience at the “University Clinical 
Center Mother Teresa” (Clinic of Gastroenterohepatology and Clinic of Abdominal Surgery) in 
Skopje, Macedonia, we propose the following algorithm for treatment of chronic anal fissure in three 
steps: from topical  nifedipine + lidocaine cream (first-line) to second course of nifedipine + 
lidocaine cream or digital anal dilatation or botulinum toxin type A injection (second-line) to lateral 
internal sphincterotomy (third-line). 
The proposed treatment algorithm allows patients to start with the least invasive treatment. There is 
no doubt that patients are willing to try less invasive modalities with the hope of avoiding surgery, 
with its risk of permanent disability. It should be up to the patients to decide which treatment they 
prefer. Although chemical sphincterotomy is less successful from lateral internal sphincterotomy, 
the algorithm allows feasibility, efficacy and cost-effectiveness, as well as risk reduction for surgical 
morbidity. 
 
 
 
 
 
 
 
Introduction 
Chronic anal fissure (CAF) is one of the most 
frequent anorectal disorders [1]. It occurs mostly 
between the second and fourth decades of life with a 
lifetime incidence of 11%; frequency is approximately 
equal between genders [2, 3]. Typical fissures are 
almost universally single, and in the posterior midline. 
Up to 10% of typical fissures in women and 1% of 
those in men are found anteriorly [4]. Up to 11% of 
women develop the condition after childbirth [5]. The 
condition is also seen in children, but it is not certain 
that there is exact comparability to CAF in adults [6].  
Symptoms vary but typically include bright red 
rectal bleeding, itching and discomfort or pain during 
and after defecation [7, 8]. The lesion may either be 
acute and self-limiting, or it may develop features of 
chronicity, including sentinel fibrous skin tag, 
hypertrophic anal papilla, exposure of the anal 
sphincter muscle fibers and elevated edges of the 
lesion. Most acute fissures heal spontaneously [8]. 
Conservative therapy consists of increased fluid and 
fiber ingestion, sitz baths, stool softeners and topical 
analgesics [7, 8]. If the fissure doesn’t heal for 6 
weeks with conservative treatment, it may be 
considered chronic. Fissures with other underlying 
pathology such as Crohn’s disease, HIV, tuberculosis, 
syphilis or anal carcinoma are excluded (secondary 
fissures). The pathophysiological mechanism for 
nonhealing remain a matter of debate [1, 9], but 
reduced local blood supply has been suggested [1, 
10]. Chronic fissure is usually associated with internal 
anal sphincter spasm, the relief of which is central to 
promote fissure healing. Treatment has undergone a 
transformation in recent years from surgical to 
medical, all approaches sharing the goal of reducing 
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the spasm [11-13]. Reduction of anal pressure by 
sphincterotomy or by anal dilatation improves 
anodermal blood flow at the posterior midline, 
resulting to fissure healing. However, the 
postoperative period may be marked by surgical risks, 
complications, and a late incidence of incontinence 
that is sometimes permanent. Recently, new 
pharmacologic therapies have been used to create a 
reversible chemical reduction of sphincter pressure 
until the fissure has healed [14].                                                               
Searches of the Cochrane Database and PubMed 
MEDLINE were performed using keywords. From the 
reviewed literature, additional articles of particular 
importance published in earlier years were identified.    
 
Treatment algorithm  
According to the researched treatment 
guidelines and the experience at the “University 
Clinical Centre Mother Teresa” (Clinic of 
Gastroenterohepatology and Clinic of Abdominal 
Surgery) in Skopje, Macedonia, we propose the 
following algorithm for treatment of CAF, which allows 
patients to start with the least invasive treatment:     
 
 
1
st
 line   
 
 
 
2
nd
 line    
 
 
 
 
3
rd
 line     
 
 
Figure 1: Treatment algorithm for chronic anal fissure 
 
First-line medical therapy 
Topical nifedipine with lidocaine 
In our treatment algorithm as first-line medical 
therapy is proposed topical nifedipine with lidocaine 
cream to be used twice daily for 21 days. Nifedipine is 
calcium channel blocker (CCB) which reduces the 
muscle tone by direct intracellular calcium depletion. 
Topical nifedipine has been associated with healing of 
chronic anal fissures in 65% to 95% of patients [15]. 
According to Cochrane reviews the healing rate is 
48.9% with fewer side effects [6]; according to Perrotti 
headache in up to 25% of patients [14]. 0.3% 
nifedipine + 1.5% lidocaine cream is present since 
June 2012 in Macedonia. There are no other 
equivalent medicines on the market. 
 
Second-line therapy 
Repeat topical nifedipine with lidocaine 
The optimal approach is further medical 
therapy with an additional course of topical nifedipine 
with lidocaine for the relapsing patients; these patients 
were treated successfully [14, 16].       
 
Digital anal dilatation after failed nifedipine 
with lidocaine     
Anal dilatation belongs to surgery procedures; 
is a simple procedure first described by Racamier in 
1829 and for many years was the primary treatment 
for CAF [17]. At the “University Clinical Centre Mother 
Teresa” is performed as out-patient procedure with 
gentle manual dilatation with four fingers without 
anaesthesia. According to Watts et al. the success 
rates are 87 to 100%, with fissure recurrence from 
16% of patients. Around 25% of patients experience 
some form of incontinence [17-18]. According to 
Hawley the average success rate ranges from 70-80% 
[19]. According to Strugnell the healing rate of CAF is 
89% [20]. Some authors support a policy of gentle 
anal dilatation as the treatment of choice [21]. 
Incontinence is a concern and endo-anal 
ultrasonography provides an insight as to the degree 
of damage associated with this procedure; 
fragmentation is often seen [18]. Experience of the 
doctor and the skills and knowledge needed for digital 
dilatations are very important, because both force and 
magnitude of the stretch have to be tailored to the 
patient. 
 
Botulinum toxin after failed nifedipine with 
lidocaine     
Botulinum toxin (BTX) is effective in treating 
fissures that have failed to heal with topical agents. It 
blocks cholinergic transmission, injected into anal 
sphincter reduces resting anal pressure, which effect 
lasts 2-3 months [22]. According to third revision of 
the American Society of Colon and Rectal Surgeons 
(ASCRS) guidelines BTX injection allows healing in 
60%-80% of fissures and higher rates than placebo 
with recurrence in up to 42% of cases. The most 
common side effects are temporary incontinence to 
flatus in up to 18% or stool in 5% and perianal 
thrombosis or hematoma [15]. According to Cochrane 
reviews BTX and CCBs are equivalent to glyceryl 
trinitrate in efficacy with fewer side effects; and they 
are all marginally but significantly better than placebo 
in healing anal fissure. Medical therapy for chronic 
anal fissure, currently consisting of topical glyceryl 
trinitrate, botulinum toxin injection or the topical 
0.3% Nifedipine +     
1.5% Lidocaine cream 
2
nd
 course of 0.3% Nifedipine  
+  1.5% Lidocaine cream 
or Digital anal dilatation 
or BTX 10 Units x 2 injections  
        Lateral internal  
       sphincterotomy 
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calcium channel blockers nifedipine or diltiazem in 
acute and chronic fissure and fissure in children may 
be applied with a chance of cure that is marginally 
better than placebo [6]. BTX can also be combined 
with nifedipine [23] or surgery [24]. Because of its cost 
and vial content of 100 U grouping of patients 
improves cost-effectiveness. At the Clinic of 
Gastroenterohepatology it is for the first time used 
since February 2014. 
 
Third-line therapy 
Lateral internal sphincterotomy after failed 
nifedipine with lidocaine     
Lateral internal sphincterotomy (LIS) is still 
considered gold standard in the treatment of CAF, 
with reported cure rates of 94-100% [6]. It carries a 
risk of incontinence to stool and flatus which ranges 
from 3% to 16% [25-27]. ASCRS also provide a strong 
recommendation for LIS as the therapy of choise [15]. 
LIS is generally contraindicated for patients with 
impaired continence, chronic diarrhea due to concrete 
chronic diseases or previous anal injuries.            
 
Conclusion 
In the search for optimal therapy for CAF, it 
should be fully understood the real physiological 
benefit provided by sphincterotomy – chemical or 
surgical. Since years there are debates worldwide 
about first-line therapy for CAF, which still continue. 
The first-line treatment of CAF with topical agents has 
led to management algorithms that can be employed 
effectively [28].  
There is no doubt that patients are willing to 
try less invasive modalities with the hope of avoiding 
surgery, with its risk of permanent disability. It should 
be up to the patients to decide which treatment they 
prefer.         
Although chemical sphincterotomy is less 
successful from LIS, the algorithm allows feasibility, 
efficacy and cost-effectiveness, as well as risk 
reduction for surgical morbidity. 
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